RPSBLAST alignment for GI: 254780290 and conserved domain: cd08295
>gnl|CDD|176255 cd08295, double_bond_reductase_like, Arabidopsis alkenal double bond reductase and leukotriene B4 12-hydroxydehydrogenase. This group includes proteins identified as the Arabidopsis alkenal double bond reductase and leukotriene B4 12-hydroxydehydrogenase. The Arabidopsis enzyme, a member of the medium chain dehydrogenase/reductase family, catalyzes the reduction of 7-8-double bond of phenylpropanal substrates as a plant defense mechanism. Prostaglandins and related eicosanoids (lipid mediators involved in host defense and inflamation) are metabolized by the oxidation of the 15(S)-hydroxyl group of the NAD+-dependent (type I 15-PGDH) 15-prostaglandin dehydrogenase (15-PGDH) followed by reduction by NADPH/NADH-dependent (type II 15-PGDH) delta-13 15-prostaglandin reductase (13-PGR) to 15-keto-13,14,-dihydroprostaglandins. 13-PGR is a bifunctional enzyme, since it also has leukotriene B(4) 12-hydroxydehydrogenase activity. Leukotriene B4 (LTB4) can be metabolized by LTB4 20-hydroxylase in inflamatory cells, and in other cells by bifunctional LTB4 12-HD/PGR. These 15-PGDH and related enzymes are members of the medium chain dehydrogenase/reductase family. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of an beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. Length = 338
Score = 59.6 bits (145), Expect = 1e-09
Identities = 70/229 (30%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 55 GLYPPP-KNANPILGLEVAGKIVDLGENTTHWNIGDEVCALVNGGGYAEYCLSHQGHTLP 113
LY PP K I G VA K+VD + +GD V G+ EY L +G L
Sbjct: 63 SLYLPPFKPGEVITGYGVA-KVVD--SGNPDFKVGDLVWGFT---GWEEYSLIPRGQDL- 115
Query: 114 IPKGYNAIQAASLPESF---------FTVWANLFQTANLRSGQTVLIHGGSSGIGTTAIQ 164
I +P S+ T +A ++ + G+TV + S +G Q
Sbjct: 116 -----RKIDHTDVPLSYYLGLLGMPGLTAYAGFYEVCKPKKGETVFVSAASGAVGQLVGQ 170
Query: 165 LASYFGATVYTTAKSEEKC-LACLKLGAKHAINYLKEDFLEILQKETQGRGIDIILDMVG 223
LA G V +A S+EK L KLG A NY +E L+ K GIDI D VG
Sbjct: 171 LAKLKGCYVVGSAGSDEKVDLLKNKLGFDDAFNYKEEPDLDAALKRYFPNGIDIYFDNVG 230
Query: 224 AEYLNQHLTLLSKEGKLII---IS-FLGGNIATEINLNPIISKRITITG 268
+ L+ L ++ G++ IS + NL II KR+ I G
Sbjct: 231 GKMLDAVLLNMNLHGRIAACGMISQYNLEWPEGVRNLLNIIYKRVKIQG 279